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Abstract
Background: PRESSURE 2 is a randomised evaluation of the clinical and cost effectiveness of two types of pressure
relieving mattress for the prevention of pressure ulcers. The primary endpoint is the time to development of a
Category ≥2 pressure ulcer. The current ‘gold standard’ for the identification of a Category ≥2 pressure ulcer is expert
clinical assessment. Due to the appearance of the bed, it is not possible to achieve blinding of the endpoint. This
therefore poses a risk to the internal validity of the study.
A possible approach is to use photographs of skin sites, with central blinded review. However, there are practical and
scientific concerns including whether patients would agree to photographs; the burden of data collection; the quality
of photographs; the completeness of data; and how the use of photographs compares with the current ‘gold
standard’. This validation sub-study aims to assess and quantify potential bias in the reporting of the trial endpoint.
Methods/design: Patients will be specifically asked to consent to photographs being taken of their skin sites.
Photographs will be taken at first observation or when patients develop a new Category ≥2 pressure ulcer (to assess
over-reporting). A 10% random sample of patients will be identified for additional photographs of two skin sites (one
torso and one limb) with and without a pressure ulcer (if present) by an independent assessor (to assess the potential
for under-reporting).
Staff will be trained to take photographs using a standardised camera and photographic technique. A ‘grey scale’ will
be included in the photo to correct white balance. Photographs will be securely transferred for central review.
Photographs will have white balance corrected, and the computer monitor will be calibrated prior to review.
Analysis will include assessment of under- and over-reporting, acceptability of photography to patients, secure transfer
of data, quality of and confidence in blinded photograph review and sensitivity analysis using photograph assessment
of primary outcome.
Discussion: This study will use photographs to contribute to the primary outcome of the trial. It will inform our
understanding of the acceptability of photography for prevention trials and the possibility of other uses of photographic
data in clinical work and research.
Trial registration: ISRCTN, ISRCTN01151335. Registered on 14 May 2013.
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Background
PRESSURE 2 is a randomised evaluation of the clinical
and cost effectiveness of two types of pressure relieving
mattresses, an alternating pressure mattress (APM) versus
a high specification foam (HSF) mattress, for the preven-
tion of pressure ulcers (PUs) [1]. The primary endpoint is
the time to development of a new Category ≥2 PU [2];
secondary objectives include comparing the time to devel-
oping a new Category 1 PU between each mattress and
cost effectiveness.
Expert clinical examination of the skin areas at risk of
PU development is the current ‘gold standard’ for the
diagnosis of the presence or absence of a PU [3, 4]. Due
to the physical differences and mode of action between
the APM and the HSF mattress, using the ‘gold standard’
of expert clinical assessment means that blinding of the
endpoint is not achievable. In a mattress trial it is not
possible to blind participants, the clinical team or the
clinical research nurse (as it is obvious if a patient is on
either an APM or a HSF mattress — due to the presence
of a pump, the sound of the pump and the appearance
of the bed and sheeting). Moving the patient to a
different mattress to assess the skin is neither ethically
appropriate, due to illness and frailty, nor practical, in
terms of nurses’ time.
This inability to perform blinded outcome assessment
poses a risk to internal validity if research nurses are in-
fluenced in some way by the mattress, with biased
under- or over-reporting of the primary endpoint
(Category ≥2 PU). That is, it is possible that the trial pri-
mary endpoint could be misreported by clinical research
staff, if there are explicit or covert preferences for one
mattress over the other. For example, this might lead to
the reporting of an area of skin damage as being second-
ary to incontinence, or being classed as not severe
enough to be a Category 2 PU, if a nurse feels that the
patient is on the ‘best’ mattress and that any damage is
‘not likely’ to be a PU. There are also potential problems
with the gold standard assessment because it is based on
the clinical appearance of the skin. There is inherent sub-
jectivity, and misclassification of the skin may also occur
[3–5]. If a trial has a potentially biased primary outcome
measure, then the findings of the trial may not be reliable,
as there is a risk that estimates of the treatment effect will
be biased. Therefore, it is important to assess and quantify
any potential bias through estimates of over-reporting and
under-reporting of Category 2 PUs.
A potential approach would be to take photographs of
skin sites and assess them centrally (blind to treatment
allocation), but to date this method has not been utilised
in a prevention trial, and there are both practical and
scientific concerns regarding its use to assess the pri-
mary endpoint: that photography would provide a high
data acquisition burden to patients, it would require two
nurses to position and photograph each patient and its
use would raise concerns about patient consent. There
are also potential concerns about image quality in ambi-
ent lighting conditions and the reliability of the identifi-
cation of a Category 2 PU using photographic evidence
[4, 5]. Further scientific and practical issues include:
1. Determining how the use of photographs compares
to the current ‘gold standard’ of expert nurse clinical
assessment in accurate diagnosis of a Category 2 PU
2. Issues regarding the aim of blinding in preventing
both differential under-reporting (false negatives)
and over-reporting (false positives) of PUs:
(a)To minimise the potential for under-reporting
would require skin photography of all main skin
sites (n = 3 photographs covering five skin sites,
sacrum, buttocks (right and left) and heels right
and left) at each visit
(b)To minimise the potential for over-reporting
would require photography only at the point of
PU development
3. Determining the ability of a photographic image to
enable the assessment of early Category 2 PUs
where the assessor has to be able to distinguish a
small red broken skin area within a bigger area of
general erythema
These issues have only been partially explored previ-
ously. We found two studies reporting the inter-rater
reliability of photography assessed by different clinical
experts and photography versus clinical assessment. One
study compared experts’ photographic assessments,
reporting levels of agreement between two groups of
experts assessing photographs to classify PUs [5]. Nine
trustees of the European Pressure Ulcer Advisory Panel
(EPUAP) reviewed 67 photographs of normal skin, PUs
of various categories and incontinence lesions. Eleven of
the photographs were eliminated, as they were assessed
by the EPUAP Trustees as being ‘insufficiently clear’.
The 11 photographs eliminated included normal skin,
non-blanching erythema and Category 2 PUs. The
remaining photographs were classified by the EPUAP
Trustees with 100% agreement for all photographs for
eight of nine Trustees. The majority EPUAP Trustee
classification was considered the ‘gold standard’. Forty-
four clinical experts then assessed the photos using a web-
based presentation. Areas of disagreement included classi-
fication of Category 1–4 PUs and incontinence lesions.
The multirater kappa for the wider expert group was 0.80.
A further study compared the ‘gold standard’ expert
clinical nurse assessment against assessment using pho-
tographs [4]. This study included 48 participants with
two photographs from each: one of a PU (including
Categories 1, 2, 3, 4 and unstageable) and one of an
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unaffected skin area. Of 32 PUs of Category ≥2 (our
endpoint), sensitivity was 97% (CI 91–100%). Of the
62 pairs of photographs with Category 1 or normal
skin, 60 were correctly classified with a specificity of
97% (CI 92–100%). Misclassifications were related to
darkly pigmented skin. However, in translation to a poten-
tial clinical trial population, it is important to acknowledge
that half the PU photographs were Category ≥3, and
therefore the photographic evidence assessed is not com-
parable to that of ‘early’ Category 2 PUs.
Other technological solutions were also considered
including laser Doppler, light spectroscopy and multi-
spectral imaging, but these detect erythema and the
intensity of skin blood flow and are unable to assess
the presence of a Category 2 PU. Therefore, recognis-
ing the need to establish a method for blinded out-
come and response to the funding body’s request, we
set up a validation sub-study within the PRESSURE 2
trial which will address both scientific and practical
questions. Therefore, recognising the need to establish
a method for blinded outcome and in response to the
funding body’s request, we set up a validation sub-
study within the PRESSURE 2 trial which will address
both scientific and practical questions.
Objectives
The main aim of the photographic validation sub-study
is to assess and quantify potential bias in the reporting
of the PRESSURE 2 trial primary endpoint. The primary
objectives of the sub-study are therefore to assess:
 Over-reporting of Category ≥2 PUs
 Under-reporting of Category ≥2 PUs
The secondary objectives of the sub-study are to assess:
 Rates of consent/potential impact on trial recruitment
 Acceptability to patients
 Compliance with photographs
 Compliance with secure transfer of photographs
between the research site and the Leeds Institute of
Clinical Trials Research (LICTR)
 Quality of photographs and confidence of
photographic review
 Inter-rater reliability of photography versus clinical
assessment
Methods/design
This sub-study is being conducted within the PRESSURE
2 trial [1], which will recruit a maximum of 2954 pa-
tients who are at ‘high risk’ of PU development. The
main trial is a multicentre trial, and the sub-study has
aimed to reflect this through recruitment of participants
from each centre. The SPIRIT flow chart and schedule
of enrolement, interventions and assessments for the
main trial are given here in Figs. 1 and 2 and Additional
file 1.
Patient consent
Details of the consent process for participants who have
capacity and those who have cognitive impairment are
Fig. 1 SPIRIT schedule of enrolment, interventions and assessments
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given in the main protocol paper [1]. When consent to
the trial is taken, patients will be specifically asked to
consent to photographs being taken of their skin sites.
An opt-out clause will allow patients to participate in
the study without consent to photographs or to with-
draw consent to photographs at any time.
Photographic data collection
Photographs will be taken whenever a new Category ≥2
PU is identified. Additionally, the following procedures
will be used.
To enable the assessment of the over-reporting of
Category ≥2 or higher PUs, a trained research nurse will
photograph all Category ≥2 PUs at first observation
(baseline or follow-up).
To assess the potential for under-reporting PUs, we will
need photographs of both ulcers and non-ulcerated skin to
be taken by an independent (blinded) assessor. The LICTR
will randomly identify 10% of patients from each centre.
Randomisation will be conducted using a central auto-
mated randomisation system with allocation concealment
at the LICTR, which will notify the Principal Investigator
(or delegate) by email when a participant has been allo-
cated to have this additional assessment. The local Princi-
pal Investigator or delegate will photograph two skin areas
including one torso and one limb skin site. If the patient
has any Category ≥2 PU, one will be photographed. If there
Fig. 2 Trial flow diagram
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is more than one Category ≥2 PU, the photographs will in-
clude one skin site with a PU and one skin site without.
To ensure photographs are obtained for 10% of those
patients recruited, the trial team will monitor compliance,
with photographs being returned on a regular basis, and
adjust the proportion of patients selected on the 24-hour
system to participate in the photography sub-study.
All photographs will be sent to the LICTR for blinded
central endpoint review by a panel of independent clinical
experts. Transfer of photographic data will comply with
data protection legislation (details are given below). The
data collection and transfer process will be monitored to
assess compliance and reasons for any non-compliance.
Information from the anonymised screening logs and
trial consent forms (opt-out of consent to photographs)
will be used to assess rates of consent to photographs
and potential impact on trial recruitment. The accept-
ability to patients will be assessed using data that will be
collected for patients not consenting to having photo-
graphs taken and for those who do consent. Reasons
why any photographs are not taken will also be
collected, e.g. ‘patient unwell’.
Sample size
In PRESSURE 2 we will be recruiting a maximum of
2954 patients with an assumed overall event rate of
20.5%. Let us assume that each patient has 3 pressure
areas (as described above) photographed 8 times in
total if they don’t develop a PU (photos to end of
study) and 4 times if they do (assuming that we stop
photographing once they have a PU). This could result in
up to (2354 × 3 × 8) + (600 × 3 × 4) – 600 = 63,096 negative
photos + 600 positive photos, totalling 63,696 photos. This
number of photographs would clearly be a burden to staff
and patients.
In light of unrealistic sample sizes and the evidence
described above suggesting problems with levels of
agreement between experts assessing photographs [5], as
well as the absence of robust evidence relating to the ac-
curacy of photographic skin assessment compared to the
current ‘gold standard’ or the availability of technological
methods of skin assessment, the first stage of a valid-
ation study is needed to address the scientific concerns.
That is, a study is needed to determine the validity of
photography versus the ‘gold standard’ expert nurse clin-
ical assessment in the assessment of Category 2 PUs.
There has been no formal sample size calculation for
this sub-study due to its exploratory nature. However,
we can anticipate the number of photographs that are
expected based on PU incidence rates from previous re-
search and the sample size of the main trial [1]. A max-
imum of ~1653 photographs are expected for the central
blinded review, which will enable kappa to be estimated
to within a precision of at least ±0.044 (corresponding to
the half width of the 95% CI), assuming 65% of photo-
graphs are of Category 2 or higher PUs and kappa ≥0.5.
To quantify the extent of over-reporting, we consider the
following. Using frequency distributions of the number of
Category ≥2 PUs observed at baseline and during follow-up
in the pain cohort study, which recruited a similar popula-
tion [6], we can expect up to 1690 new PUs to be photo-
graphed, corresponding to 803 PUs at baseline (27.2% of
patients recruited) and 878 PUs that develop during follow-
up (from 605 (20.5%) participants). The true number is
likely to be lower due to consent rates for photography,
which could change throughout the study. For example, a
patient could provide consent for photographs to be taken
at baseline, but at a subsequent visit he/she may not pro-
vide consent for further photographs to be taken.
To assess under-reporting, the following is considered.
We expect 296 patients to be selected for this part of the
study. Assuming they are assessed close to the baseline visit
and assuming the proportion of patients observed to have a
PU at baseline similar to that in the pain cohort study
(27.2%), then we can expect 80 photographs of PUs and
512 photographs of PU-free skin sites, providing a total of
774 photographs from the independent assessment.
Therefore, a maximum of 2455 photographs corre-
sponding to 1943 PU photographs and 512 pressure-
ulcer free photographs can be expected to be received
and reviewed by the central review panel.
Camera and photographs
The expertise of an independent professional medical
photographer was sought for camera selection, testing
and standardisation of photographs.
Choice of camera
A practical consideration of the study was the cost of
supplying 50 cameras to sites taking part in the study. A
digital single-lens reflex (DSLR) camera with macro lens
and flash could cost £1000–£3000 per unit depending
on quality. Compact cameras recommended by the
Institute of Medical Illustrators (IMI) National Guidelines
on Wound Management [7] such as the Nikon Coolpix
P7100 costing £345 per camera would cost the study
£17,250. With consideration to the available budget of the
study, potential affordable camera models were tested
using a ColorChecker Color Rendition Chart to assess
colour accuracy. The selected camera, the Canon IXUS
510 HS, was then tested further to assess the best settings
and shooting distances to standardise the cameras.
The study planned to use the same model Canon
IXUS 510 HS camera for more consistent results. Differ-
ent camera models, even by the same manufacturer, will
use different sensors, lenses and firmware. Inconsistent
use of cameras could make a difference in the quality of
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the images, in particular if the camera had a colour bias,
and therefore could affect the assessment of the PU.
Camera testing
The setup of the camera was considered and a guide
produced to standardise the functions of the camera.
The flash was set up to be the primary lighting source in
all images and a fixed shooting mode recommended so
that the camera would not vary in different lighting set-
tings across all of the units involved in the study. By
manually setting up the camera settings, the Inter-
national Standards Organisation (ISO), exposure com-
pensation, white balance, light metering and colour
settings could all be programmed for consistent results.
A shooting distance of 30 cm between the camera and
skin site was recommended so that the built-in flash
would not overexpose the subject area.
Unknown variables such as unit lighting conditions were
considered and a grey scale produced for inclusion in the
photographs. Including a grey scale would allow LICTR
personnel to process the submitted images to a more ac-
curate colour by using a corrected white balance. By using
a grey scale to correct colour during post processing, this
workflow would enable the study to achieve a more con-
sistent result in the images produced. Figures 3 and 4
demonstrate the effect of correction of white balance. See
Fig. 5 for an example of the grey scale card used in every
photograph.
Standardisation of photography technique
A study camera will be supplied to each site together with
a work instruction detailing the use of a standardised
photographic method including the use of grey scales for
white balance and camera settings, e.g. ISO setting, etc. For
consistency and interpretation of photographic data, it was
deemed imperative that only the study camera supplied will
be used to take photographs. In addition, the work instruc-
tion will provide clear instructions on the anonymisation,
secure transfer and deletion of the photographs (that is,
there will be no local storage of photographs on the camera
or National Health Service (NHS) computer).
Safe transfer of photographs
To ensure the safe transfer of photographs, the LICTR
will create an NHS mail email account so that sites can
email photographs from their personal NHS mail email
account to the study coordinating centre via a secure
electronic pathway. This method of transfer for patient
sensitive data is in compliance with NHS data transfer
policy. During centre setup, site staff will be requested
to apply for an NHS mail email account if they do not
already have one. Authorised members of staff at the
LICTR will be given access to the LICTR NHS mail
email account and will check the account on a daily
basis for new emails containing photographs. When an
email containing a photograph is received, the photo-
graph is downloaded and saved in a restricted access
folder on the secure server at the LICTR. The file will be
saved in the following format: Participant Trial Num-
ber_Body Site Photographed_Date of Photograph_Time
of Photograph. The site will then be emailed to confirm
receipt of the photograph and to request the member of
staff at the site to delete the photograph from their
Fig. 4 Colour accuracy out of camera: post white balance
Fig. 3 Colour accuracy out of camera: auto white balance Fig. 5 Example of grey scale card used in each photograph
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camera, computer and email outbox. If a response from
the LICTR is not received within 24 hours of the photo-
graph being sent, the site will be requested to call the
LICTR to check whether the photograph has been re-
ceived. The LICTR will log each photograph and assign
a unique 5-digit number in order to anonymise the
photograph before it is reviewed. The LICTR will then
delete the email containing the photograph from the
NHS mail account and clear the downloaded file from
their Internet history to ensure that the photograph is
not accessible via an unsecure server.
Standardisation of photograph quality and independent
expert review
Prior to central review by the expert clinical panel, the
LICTR will ensure that the image has a corrected white
balance, is cropped and is made anonymous to the
reviewers. To achieve this, the photograph will be imported
into the Adobe Lightroom software. The included grey
scale in the image will then be used as a reference for the
software to correct the white balance to a true white for
the lighting conditions under which the photograph was
taken. Once it has been corrected, the grey scale card is
cropped out of the picture so that no participant details are
visible during the clinical review. The photograph will then
be saved in a separate folder on the secure server with the
file name in the following format: Body Site Photographed-
unique 5-digit photograph number. The photograph will
then be deleted from the Adobe Lightroom software and
entered as ‘Processed – Waiting for Review’ on a spread-
sheet used to log the receipt of each photograph.
During the central photographic review, the reviewers will
be expected to document their assessment of the skin site
using the EPUAP classification scale [2]. They will also be
asked to report any Category 1 pressure damage identified
and classify other skin abnormalities, e.g. moisture damage,
eczema, etc. It is recognised that, despite clear instructions,
the photographs will not be taken by medical photographers
and therefore may not be of high quality. Also, identifying
Category 1 damage requires a combination of visual and
manual examination of the skin, and the diagnosis of other
skin conditions requires details of the clinical history. As the
central reviewers will be asked to make a decision on the
photograph alone, they will be asked to rate their confidence
in their decision using an adapted 11-point scale ranging
from 0 (Not confident at all) to 10 (Very confident) [8].
Three members of the central review panel will independ-
ently review the photographs; the assessment used for sum-
maries and analysis will be the category for which there are
at least two members of the panel in agreement.
On the day of each review, the computer monitor on
which each photograph will be viewed is calibrated using
the Spyder 4 Pro Advanced Monitor Calibration software
to ensure that the colours in the photograph are displayed
as accurately as possible on the assessment monitor. Wher-
ever possible the same computer monitor will be used for
each review to minimise the impact of variations such as
ambient light in the room. During the review each member
of the expert clinical panel will be asked to view the photo-
graph on the screen one at a time and record their assess-
ment on a trial case report form (CRF) including the Body
Site Photographed and the unique 5-digit photograph num-
ber for identification purposes. A member of the LICTR
will be present at each review session to ensure that the
panel members do not discuss details of their assessment.
Following each review, the CRF will be ‘unblinded’ by
the LICTR by linking the unique 5-digit photograph
number to the correct participant number and entered
into the trial database.
Analysis
Assessing risk of over-reporting
A sensitivity analysis will be conducted in addition to
the main trial primary analysis whereby the primary end-
point will be replaced by the primary endpoint that
would have been derived if the assessment made by the
blinded central endpoint review of photographs had
been used. That is, for all Category ≥2 PUs that were re-
ported by the research nurse, these assessments will be
replaced with the assessments made by the blinded cen-
tral endpoint review. The primary endpoint will remain
the same for skin sites that were not assessed as
Category ≥2 by the research nurse or for those for which
photographs were not received.
Assessing risk of under-reporting
For each skin site assessed by the local Principal Investi-
gator (or delegate), a 2 × 2 table will be produced to
summarise whether the skin assessments made by the
local Principal Investigator (or delegate) and the skin
assessments made by the research nurse agree on the
Category ≥2 PU status on a patient level. In addition,
there will be a 2 × 2 table summarising the agreement
across all skin sites.
For the skin sites photographed by the local Principal
Investigator (or delegate), 2 × 2 tables will be produced
for each skin site and overall to summarise the agree-
ment on the Category ≥2 PU status for each of the fol-
lowing comparisons:
 Assessments drawn from the photographs (from
blinded central review) and the skin assessments
made by the local Principal Investigator (or delegate)
 Assessments drawn from the photographs (from
blinded central review) and the skin assessments
made by the research nurse, and also
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 Clinical skin assessments made by the local Principal
Investigator (or delegate) and the skin assessments
made by the research nurse
Kappa and prevalence and bias adjusted kappa statis-
tics will be reported for each of these tables [9, 10].
Rates of consent/potential impact on trial recruitment
To assess the rates of consent/potential impact on trial re-
cruitment, the reasons for not being recruited to the main
trial will be summarised to identify whether photography
is preventing patients from entering the trial. This is not
expected to be a reason for non-randomisation, because
the photography sub-study is optional. Therefore, the
consent rate for the photography sub-study will be
summarised.
Acceptability to patients
To assess the acceptability to patients, the reasons for
photographs not being attempted will be summarised
and tracked over time to identify whether consent for
photographs to be taken is withdrawn at a later date.
Compliance with photographs
Summaries of whether a photograph is expected based
on the skin assessment or identification on the 24-hour
system will be produced. Reasons for non-compliance
(where available) will be summarised. Compliance with
the protocol for taking photographs will also be sum-
marised, such as whether the grey scale card was used.
Compliance with secure transfer of photographs
Summaries of any deviations from the work instruction
for the secure transfer of photographs from the research
site and the LICTR will be presented, together with any
remedial action taken.
Quality of photographs and confidence of photographic
review
The number of photographs considered to be unable to
be assessed will be summarised together with the reasons.
The confidence of the photographic assessments will be
summarised overall and also where any discrepancies arise
between the photographic and clinical assessments. List-
ings and summaries of each reviewer’s assessment of each
photograph will be produced to identify whether there are
any particular skin sites or category of PUs that cause dif-
ficulties when PU photographs are assessed.
Discussion
A validation sub-study, using photography with blinded
central review, will be carried out to assess any under-
reporting or over-reporting of Category ≥2 PUs and
establish whether future trials can utilise central review
of photography for blinded primary outcome
assessment.
Guidelines which have been prepared for use by pro-
fessional medical illustrators exist for clinical photog-
raphy of patients’ wounds [7]. This study acknowledges
the application of these guidelines would be the ‘gold
standard’ in photography, but the need for a pragmatic
approach dictated the process used.
As per IMI National Guidelines, the use of cameras on
mobile phones could not be allowed because it would
introduce unacceptable risks of compromising patient
privacy. Along with budget considerations, this left only
the choice of consumer compact cameras as a viable op-
tion. Since the study was set up, hybrid cameras, entry-
level DSLR cameras and compact system cameras
(CSCs) have improved and prices lowered, although not
to the same level as for the sub £100 compacts tested
for the study.
The camera selected for the study, a Canon IXUS 510
HS, has a 10-megapixel complementary metal-oxide-
semiconductor (CMOS) sensor with a Digic 5 processor
and a 35 mm equivalent: 28-336 mm f/3.4–5.6 lens. As
the images taken would need to be emailed and would
be assessed on a monitor, the 10-megapixel resolution
would not be a significant issue.
As the study would be utilising non-professional pho-
tographers to photograph the patients, the workflow for
the study would be limited. As most photography would
take place on wards over multiple sites across the coun-
try, there would be little control or consistency between
backgrounds and ambient lighting. The study recom-
mended that lighting should always be with the camera’s
flash. The white balance was to be set to Auto, as the
camera did not include a flash white balance setting.
This was a contributing factor to the use of a basic grey
scale. The auto white balance (AWB) setting would
automatically set the white balance of the camera to the
optimal settings of the environment. With inconsistent
environmental lighting the AWB colour setting needed
to be corrected to a standardised reference point.
Commercial grey scales and colour rendition charts
are available. The Xrite ColorChecker Passport, a
pocket-sized version with its own camera calibration
software, was tested. This could be considered the ‘gold
standard’ for automating colour correction and white
balance of the images produced by a camera. This soft-
ware was only able to calibrate and create custom Digital
Negative (DNG) profiles. Consumer cameras at the
budget level tested most commonly output images to a
JPEG file format, not a DNG RAW file. At a cost of £80
per chart, purchasing these charts to use as a grey scale
would double the setup costs for the study. A further
consideration was the risk of infection. The decision was
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taken to produce a disposable grey scale specifically for
the study. This would give a target of white balancing
images as well as including vital study information.
One noteworthy issue that would be encountered dur-
ing the setup of such a study is the ongoing obsoles-
cence lifecycle of consumer technology. The Canon
IXUS 510 HS was known to be at the end of its produc-
tion cycle after the initial bulk purchase of cameras. This
means that the new centres will have to use a different
model of camera that will not be consistent with the
standardisation set up for the study.
We will also be assessing the practical aspects of using
photography such as acceptability to patients, potential
impact on trial recruitment, compliance with taking
photographs, reasons for non-compliance, whether nurs-
ing staff (amateur photographers) can produce reliable
photographs given the constraints of the clinical envir-
onment and patient positions and whether photographs
can be used to assess the trial endpoint.
There are ethical issues associated with photography
of PUs and skin areas at ‘high risk’ of PU development
(e.g. sacrum and buttocks). The use of photography was
discussed at a Pressure Ulcer Research Service User
Network (PURSUN) meeting. PURSUN is a group of
people with personal experience of PUs who are sup-
porting the PRESSURE 2 study. A member of PURSUN
with experience in having a PU photographed also
helped to develop the PRESSURE 2 protocol and pho-
tography instructions.
Input from PURSUN led to some important measures
being put in place to minimise participant burden,
improve recruitment and maintain dignity:
 Verbal agreement is required at the time the
photograph is taken, even if written consent has
already been obtained.
 Photographs are taken by a registered healthcare
professional (not a medical photographer).
 The photography instructions stress that patient
comfort, privacy and dignity are paramount when
positioning people for photographs.
 Participants are able to opt out of the photography
sub-study but still remain in the trial.
If we find that only a significant minority of patients
do not find photography of body sites acceptable or that
the findings of the sub-study do not agree sufficiently
with the clinical review, then this will affect its utility for
central blinded review and the primary outcome meas-
ure in future trials.
Consideration will be given to the clinical application
of wound photographs for the assessment of wounds.
With the increasing use of ‘telemedicine’ and remote
clinical assessments of patients with wounds and other
skin conditions, it will be important to know the confi-
dence in the accuracy of the remote assessment.
There is very little known regarding the pathophysi-
ology of PU development due to issues such as ethical
concerns about skin and wound biopsy of these patients
[11]. It is possible that in the future, if photography is
deemed acceptable to patients, photographic data col-
lected in trials such as PRESSURE 2 could be used for
further analysis, e.g. informing the pathophysiological
development of PUs.
Additionally, training staff on skin and wound assess-
ment is often difficult at the bedside due to acuity of
illness, poor lighting, patient position and comfort. With
permissions these photographs could be used for train-
ing purposes.
PRESSURE 2 will be the first PU prevention trial, to
our knowledge, to use photographic information to con-
tribute to the primary outcome. We need to understand
the acceptability of photography for prevention trials,
where missing data can reduce the power and internal
validity of the trial. In leg ulcer healing studies there are
a small number of high-quality trials in which the out-
come has been validated through photography [12, 13].
It is not currently understood whether patients will
allow photography of PUs and intact skin over bony
prominences such as the sacrum, buttocks and hips dur-
ing trial follow-up.
Trial status
The first patient was randomised on 14 August 2013. As
of 13 April 2016, 1501 patients had been randomised.
Recruitment finished on 30 November 2016 with a total
of 2030 patients recruited.
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